维普中文期刊产品整合服务
17篇 您的检索式:作者名="Fidalgo S"
    题名 作者 年代 出处 被引量
1Rapid determina- tion of polyether marine toxins using liquid chromatogra- phy-multiple tandem mass spectrometry显示文摘PATRICIA FERN'ANDEZ PUENTE MAR'IA JOS'E FIDALGO S'AEZ BRETT HAMILTON 2004Journal of Chromatography2004,1056,:1
2Serotonin: from top to bottom 显示文摘Fidalgo S Ivanov DK Wood SH 2013Biogerontology2013,14,1:1
3Detection of Mutations in Mismatch Repair Genes in Protuguese Families with Heredatary Non-polyposis Colcrectal Cancer by a Multi-method Approach显示文摘Fidalgo P Almenda M R West S 2008Eur J Jum Gene2008,8,:1
4Effect of high- pressure pre- treatments on enzymatic activities of Atlantic mackerel( Scomber scombrus ) during frozen storage 显示文摘Fidalgo L G Saraiva J A Aubourg S P 2014Innovative Food Science & Emerging Technologies2014,23,6:1
5Surface-induced droplet fusion in microfluidic devices显示文摘Fidalgo L M Abell C Huck W T S 2007Lab Chip2007,7,:1
6A study of a microstructure-dependent composite laminated Timoshenko beam using a modified couple stress theory and a meshless method显示文摘Roque C M C Fidalgo D S Ferreira A J M Reddy J N 2013Composite Structures2013,96,0:1
7New pharmacological perspective and therapeutic of PPAR -γ agonists显示文摘Alarcon de la Lastra C Sanchez - Fidalgo S Villegas I 2004Curr Pharm Des2004,10,28:1
8Hybrid silica/polymer aerogals dried at ambient pressure 显示文摘Fidalgo A F arinha J P S Martinho J M G 2007Chemistry of Materials2007,19,10:1
9Detection of mutationsin mismatch repair genes in portuguese families with hereditarynon-polyposis colorectal cancer(HNPCC)by a multi-method ap-proach显示文摘Fidalgo P Almeida MR West S 2000Eur J Hum Genet2000,8,1:1
10Dexmedetomidine attenuates isoflurane-induced neurocogni- rive impairment in neonatal rats 显示文摘Sanders RD Xu J Shu Y Januszewski A Halder S Fidalgo A 2009Anesthesiology2009,110,5:1
11The urban heat island in Salamanca(Spain)and its relationship to meteorological parameters显示文摘Alonso M S Fidalgo M R Labajo J L 2007Climate Research2007,34,:1
12显示文摘Fidalgo A Farinha J P S 2007Chem Marer2007,19,:1
13Endoscopic mucosal resec-tion of superficial colorectal neoplasms : review of 140 procedures显示文摘Serrano M M3o de Ferro S Fidalgo P 2012ActaMed Port2012,25,5:1
14Effect of high- pressure pre-trealments on enzymatic activities of At|antic mackerel (Scomberscombrus) during frozen storage 显示文摘Fidalgo L G Saraiva J A Aubourg S P 2014Inno- vative Food Science g Emerging Technologies2014,23,6:1
15A study of a microstructure-dependent composite laminated Timoshenko beam using a modified couple stress theory and a meshless method显示文摘ROQUE C M C FIDALGO D S FERREIRA A J M 2013Composite Structures2013,96,4:1
16Climate Changes in Brazil: the Expected Financial Benefits by Implementing Smart Grids as a Mitigation and Adaptation Strategy显示文摘Débora de Sāo José José Ntmo Fidalgo 2017Journal of Environmental Science and Engineering(B)2017,6,10:0
17Septic shock 3.0 criteria application in severe COVID-19 patients:An unattended sepsis population with high mortality risk显示文摘BACKGROUND Coronavirus disease 2019(COVID-19)can be associated with life-threatening organ dysfunction due to septic shock,frequently requiring intensive care unit(ICU)admission,respi-ratory and vasopressor support.There-fore,clear clinical criteria are pivotal for early recognition of patients more likely to need prompt organ support.Although most patients with severe COVID-19 meet the Sepsis-3.0 criteria for septic shock,it has been increasingly recognized that hyperlactatemia is frequently absent,possibly leading to an underestimation of illness severity and mortality risk.AIM To identify the proportion of severe COVID-19 patients with vasopressor support requirements,with and without hyperlactatemia,and describe their clinical outcomes and mortality METHODS We performed a single-center prospective cohort study.All adult patients admitted to the ICU with COVID-19 were included in the analysis and were further divided into three groups:Sepsis group,without both criteria;Vasoplegic Shock group,with persistent hypotension and vasopressor support without hyperlactatemia;and Septic Shock 3.0 group,with both criteria.COVID-19 was diagnosed using clinical and radiologic criteria with a severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)positive RT-PCR test.RESULTS 118 patients(mean age 63 years,87%males)were included in the analysis(n=51 Sepsis group,n=26 Vasoplegic Shock group,and n=41 Septic Shock 3.0 group).SOFA score at ICU admission and ICU length of stay were different between the groups(P<0.001).Mortality was significantly higher in the Vasoplegic Shock and Septic Shock 3.0 groups when compared with the Sepsis group(P<0.001)without a significant difference between the former two groups(P=0.713).The log rank tests of Kaplan-Meier survival curves were also different(P=0.007).Ventilator-free days and vasopressor-free days were different between the Sepsis vs Vasoplegic Shock and Septic Shock 3.0 groups(both P<0.001),and similar in the last two groups(P=0.128 and P=0.133,respectively).Logistic regression identified the maximum dose of vasopressor therapy used(AOR 1.046;95%CI:1.012-1.082,P=0.008)and serum lactate level(AOR 1.542;95%CI:1.055-2.255,P=0.02)as the major explanatory variables of mortality rates(R20.79).CONCLUSION In severe COVID-19 patients,the Sepsis 3.0 criteria of septic shock may exclude approximately one third of patients with a similarly high risk of a poor outcome and mortality rate,which should be equally addressed.JoséPedro Cidade LM Coelho Vasco Costa Rui Morais Patrícia Moniz Luís Morais Pedro Fidalgo António Tralhão Carolina Paulino David Nora Bernardino Valério Vítor Mendes Camila Tapadinhas Pedro Povoa 2022World Journal of Critical Care Medicine2022,11,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费